Prolactin regulates TRPV1, TRPA1, and TRPM8 in sensory neurons in a sex-dependent manner: Contribution of prolactin receptor to inflammatory pain

American Journal of Physiology - Endocrinology and Metabolism

Volumn 305, Issue 9, 2013, Pages

  Patil, Mayur J ^a   Ruparel, Shivani B ^b   Henry, Michael A ^b   Akopian, Armen N ^a,b  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Female; Inflammation; Pain; Prolactin receptor; Transient receptor potential A1; Transient receptor potential M8; Transient receptor potential V1

Indexed keywords

ALLYL ISOTHIOCYANATE; CAPSAICIN; FREUND ADJUVANT; MENTHOL; PROLACTIN; PROLACTIN RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; VANILLOID RECEPTOR 1;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; COLD SENSITIVITY; CONTROLLED STUDY; FEMALE; FOREFOOT; GENE EXPRESSION; GENE SILENCING; HEAT SENSITIVITY; HYPERALGESIA; INFLAMMATORY PAIN; INTERSTITIAL FLUID; KNOCKOUT MOUSE; MALE; MECHANICAL ALLODYNIA; MECHANICAL STIMULATION; MOUSE; NONHUMAN; PAIN RECEPTOR; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT; REGULATORY MECHANISM; SENSITIZATION; SENSORY NERVE CELL; SEX DIFFERENCE; SPINAL CORD; SPINAL CORD DORSAL HORN; SPINAL GANGLION; WILD TYPE;

FEMALE; INFLAMMATION; PAIN; PROLACTIN RECEPTOR; TRANSIENT RECEPTOR POTENTIAL A1; TRANSIENT RECEPTOR POTENTIAL M8; TRANSIENT RECEPTOR POTENTIAL V1;

ANIMALS; BEHAVIOR, ANIMAL; COLD TEMPERATURE; FEMALE; GANGLIA, SPINAL; HOT TEMPERATURE; HYPERALGESIA; INFLAMMATION; MALE; MICE; MICE, KNOCKOUT; NOCICEPTORS; PAIN; PHYSICAL STIMULATION; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PROLACTIN; SENSORY RECEPTOR CELLS; SEX CHARACTERISTICS; TRPC CATION CHANNELS; TRPM CATION CHANNELS; TRPV CATION CHANNELS;

EID: 84886996702     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00187.2013     Document Type: Article

References (77)

1. Adan N, Guzman-Morales J, Ledesma-Colunga MG, Perales-Canales SI, Quintanar-Stephano A, Lopez-Barrera F, Mendez I, Moreno-Carranza B, Triebel J, Binart N, Martinez de la Escalera G, Thebault S, Clapp C. Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis. J Clin Invest 123: 3902-3913, 2013.
2. Akopian AN, Ruparel NB, Jeske NA, Hargreaves KM. Transient receptor potential TRPA1 channel desensitization in sensory neurons is agonist dependent and regulated by TRPV1-directed internalization. J Physiol 583: 175-193, 2007.
3. Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ, Earley TJ, Patapoutian A. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 41: 849-857, 2004.
4. Barnabe C, Bessette L, Flanagan C, Leclercq S, Steiman A, Kalache F, Kung T, Pope JE, Haraoui B, Hochman J, Mosher D, Thorne C, Bykerk V. Sex differences in pain scores and localization in inflammatory arthritis: a systematic review and metaanalysis. J Rheumatol 39: 1221-1230, 2012.
5. Bautista DM, Jordt SE, Nikai T, Tsuruda PR, Read AJ, Poblete J, Yamoah EN, Basbaum AI, Julius D. TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents. Cell 124: 1269-1282, 2006.
6. Bautista DM, Siemens J, Glazer JM, Tsuruda PR, Basbaum AI, Stucky CL, Jordt SE, Julius D. The menthol receptor TRPM8 is the principal detector of environmental cold. Nature 448: 204-208, 2007.
7. Berczi I, Nagy E, Asa SL, Kovacs K. The influence of pituitary hormones on adjuvant arthritis. Arthritis Rheum 27: 682-688, 1984.
8. Bernichtein S, Kayser C, Dillner K, Moulin S, Kopchick JJ, Martial JA, Norstedt G, Isaksson O, Kelly PA, Goffin V. Development of pure prolactin receptor antagonists. J Biol Chem 278: 35988-35999, 2003.
9. Bernton EW, Meltzer MS, Holaday JW. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239: 401-404, 1988.
10. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19: 225-268, 1998.
11. Bolyakov A, Paduch DA. Prolactin in men's health and disease. Curr Opin Urol 21: 527-534, 2011.
12. Bonnington JK, McNaughton PA. Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J Physiol 551: 433-446, 2003.
13. Book McAlexander M, Yu-Lee L. Prolactin activation of IRF-1 transcription involves changes in histone acetylation. FEBS Lett 488: 91-94, 2001.
14. Boucher TJ, Okuse K, Bennett DL, Munson JB, Wood JN, McMahon SB. Potent analgesic effects of GDNF in neuropathic pain states. Science 290: 124-127, 2000.
15. Bradshaw H, Miller J, Ling Q, Malsnee K, Ruda MA. Sex differences and phases of the estrous cycle alter the response of spinal cord dynorphin neurons to peripheral inflammation and hyperalgesia. Pain 85: 93-99, 2000.
16. Butelman ER, Harris TJ, Perez A, Kreek MJ. Effects of systemically administered dynorphin A(1-17) in rhesus monkeys. J Pharmacol Exp Ther 290: 678-686, 1999.
17. Caligioni CS. Assessing reproductive status/stages in mice. Curr Protoc Neurosci Appendix 4: Appendix 4I, 2009.
18. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288: 306-313, 2000.
19. Ceyhan GO, Schafer KH, Kerscher AG, Rauch U, Demir IE, Kadihasanoglu M, Bohm C, Muller MW, Buchler MW, Giese NA, Erkan M, Friess H. Nerve growth factor and artemin are paracrine mediators of pancreatic neuropathy in pancreatic adenocarcinoma. Ann Surg 251: 923-931, 2011.
20. Clement-Lacroix P, Ormandy C, Lepescheux L, Ammann P, Damotte D, Goffin V, Bouchard B, Amling M, Gaillard-Kelly M, Binart N, Baron R, Kelly PA. Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology 140: 96-105, 1999.
21. Clevenger CV, Kline JB. Prolactin receptor signal transduction. Lupus 10: 706-718, 2001.
22. Colburn RW, Lubin ML, Stone DJ Jr, Wang Y, Lawrence D, D'Andrea MR, Brandt MR, Liu Y, Flores CM, Qin N. Attenuated cold sensitivity in TRPM8 null mice. Neuron 54: 379-386, 2007.
23. Cook CD, Nickerson MD. Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund's adjuvant-induced arthritic male and female rats. J Pharmacol Exp Ther 313: 449-459, 2005.
24. Corbacho AM, Valacchi G, Kubala L, Olano-Martin E, Schock BC, Kenny TP, Cross CE. Tissue-specific gene expression of prolactin receptor in the acute-phase response induced by lipopolysaccharides. Am J Physiol Endocrinol Metab 287: E750-E757, 2004.
25. Dai Y, Wang S, Tominaga M, Yamamoto S, Fukuoka T, Higashi T, Kobayashi K, Obata K, Yamanaka H, Noguchi K. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J Clin Invest 117: 1979-1987, 2007.
26. De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A. Prolactin and autoimmunity. Pituitary 8: 25-30, 2005.
27. Diogenes A, Patwardhan AM, Jeske NA, Ruparel NB, Goffin V, Akopian AN, Hargreaves KM. Prolactin modulates TRPV1 in female rat trigeminal sensory neurons. J Neurosci 26: 8126-8136, 2006.
28. Eyal O, Jomain JB, Kessler C, Goffin V, Handwerger S. Autocrine prolactin inhibits human uterine decidualization: a novel role for prolactin. Biol Reprod 76: 777-783, 2007.
29. Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL 3rd. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 10: 447-485, 2009.
30. Gardell LR, Wang R, Ehrenfels C, Ossipov MH, Rossomando AJ, Miller S, Buckley C, Cai AK, Tse A, Foley SF, Gong B, Walus L, Carmillo P, Worley D, Huang C, Engber T, Pepinsky B, Cate RL, Vanderah TW, Lai J, Sah DW, Porreca F. Multiple actions of systemic artemin in experimental neuropathy. Nat Med 9: 1383-1389, 2003.
31. Giraldo E, Hinchado MD, Garcia JJ, Ortega E. Influence of gender and oral contraceptives intake on innate and inflammatory response. Role of neuroendocrine factors. Mol Cell Biochem 313: 147-153, 2008.
32. Gregus AM, Doolen S, Dumlao DS, Buczynski MW, Takasusuki T, Fitzsimmons BL, Hua XY, Taylor BK, Dennis EA, Yaksh TL. Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors. Proc Natl Acad Sci USA 109: 6721-6726, 2012.
33. Grimaldi G, Christian M, Steel JH, Henriet P, Poutanen M, Brosens JJ. Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells. Mol Endocrinol 25: 1892-1903, 2011.
34. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88, 1988.
35. Hilty C, Bruhlmann P, Sprott H, Gay RE, Michel BA, Gay S, Neidhart M. Altered diurnal rhythm of prolactin in systemic sclerosis. J Rheumatol 27: 2160-2165, 2000.
36. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E, Dorshkind K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16: 6926-6935, 1997.
37. Jeske NA, Patwardhan AM, Gamper N, Price TJ, Akopian AN, Hargreaves KM. Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons. J Biol Chem 281: 32879-32890, 2006.
38. Jimena P, Aguirre MA, Lopez-Curbelo A, de Andres M, Garcia-Courtay C, Cuadrado MJ. Prolactin levels in patients with systemic lupus erythematosus: a case controlled study. Lupus 7: 383-386, 1998.
39. Khan AA, Diogenes A, Jeske NA, Henry MA, Akopian A, Hargreaves KM. Tumor necrosis factor alpha enhances the sensitivity of rat trigeminal neurons to capsaicin. Neuroscience 155: 503-509, 2008.
40. Kwan KY, Allchorne AJ, Vollrath MA, Christensen AP, Zhang DS, Woolf CJ, Corey DP. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron 50: 277-289, 2006.
41. Lin SH, Leslie FM, Civelli O. Neurochemical properties of the prolactin releasing peptide (PrRP) receptor expressing neurons: evidence for a role of PrRP as a regulator of stress and nociception. Brain Res 952: 15-30, 2002.
42. Lyons DJ, Hellysaz A, Broberger C. Prolactin regulates tuberoinfundibular dopamine neuron discharge pattern: novel feedback control mechanisms in the lactotrophic axis. J Neurosci 32: 8074-8083, 2012.
43. Madaan V, Bestha DP, Kolli V, Jauhari S, Burket RC. Clinical utility of the risperidone formulations in the management of schizophrenia. Neuropsychiatr Dis Treat 7: 611-620, 2011.
44. Malin SA, Molliver DC, Koerber HR, Cornuet P, Frye R, Albers KM, Davis BM. Glial cell line-derived neurotrophic factor family members sensitize nociceptors in vitro and produce thermal hyperalgesia in vivo. J Neurosci 26: 8588-8599, 2006.
45. Mateo L, Nolla JM, Bonnin MR, Navarro MA, Roig-Escofet D. High serum prolactin levels in men with rheumatoid arthritis. J Rheumatol 25: 2077-2082, 1998.
46. Matera L. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 59: 599-614, 1996.
47. McKemy DD, Neuhausser WM, Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416: 52-58, 2002.
48. Mena F, Gonzalez-Hernandez A, Navarro N, Castilla A, Morales T, Rojas-Piloni G, Martinez-Lorenzana G, Condes-Lara M. Prolactin fractions from lactating rats elicit effects upon sensory spinal cord cells of male rats. Neuroscience 248C: 552-561, 2013.
49. Milano W, D'Acunto CW, De Rosa M, Festa M, Milano L, Petrella C, Capasso A. Recent clinical aspects of hyperprolactinemia induced by antipsychotics. Rev Recent Clin Trials 6: 52-63, 2012.
50. Millan MJ, Czlonkowski A, Pilcher CW, Almeida OF, Millan MH, Colpaert FC, Herz A. A model of chronic pain in the rat: functional correlates of alterations in the activity of opioid systems. J Neurosci 7: 77-87, 1987.
51. Moderscheim TA, Gorba T, Pathipati P, Kokay IC, Grattan DR, Williams CE, Scheepens A. Prolactin is involved in glial responses following a focal injury to the juvenile rat brain. Neuroscience 145: 963-973, 2007.
52. Neidhart M, Fluckiger EW. Hyperprolactinaemia in hypophysectomized or intact male rats and the development of adjuvant arthritis. Immunology 77: 449-455, 1992.
53. Neziri AY, Curatolo M, Nuesch E, Scaramozzino P, Andersen OK, Arendt-Nielsen L, Juni P. Factor analysis of responses to thermal, electrical, and mechanical painful stimuli supports the importance of multi-modal pain assessment. Pain 152: 1146-1155, 2011.
54. Neziri AY, Scaramozzino P, Andersen OK, Dickenson AH, Arendt-Nielsen L, Curatolo M. Reference values of mechanical and thermal pain tests in a pain-free population. Eur J Pain 15: 376-383, 2011.
55. Obreja O, Rathee PK, Lips KS, Distler C, Kress M. IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C. FASEB J 16: 1497-1503, 2002.
56. Ochoa-Amaya JE, Malucelli BE, Cruz-Casallas PE, Nasello AG, Felicio LF, Carvalho-Freitas MI. Dual effects of hyperprolactinemia on carrageenan-induced inflammatory paw edema in rats. Neuroimmunomodulation 18: 245-253, 2011.
57. Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N, Kelly PA. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 11: 167-178, 1997.
58. Patwardhan AM, Scotland PE, Akopian AN, Hargreaves KM. Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc Natl Acad Sci USA 106: 18820-18824, 2009.
59. Pi X, Voogt JL, Grattan DR. Detection of prolactin receptor mRNA in the corpus striatum and substantia nigra of the rat. J Neurosci Res 67: 551-558, 2002.
60. Qazi AM, Tsai-Morris CH, Dufau ML. Ligand-independent homo-and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization. Mol Endocrinol 20: 1912-1923, 2006.
61. Ren K, Blass EM, Zhou Q, Dubner R. Suckling and sucrose ingestion suppress persistent hyperalgesia and spinal Fos expression after forepaw inflammation in infant rats. Proc Natl Acad Sci USA 94: 1471-1475, 1997.
62. Reuwer AQ, van Eijk M, Houttuijn-Bloemendaal FM, van der Loos CM, Claessen N, Teeling P, Kastelein JJ, Hamann J, Goffin V, von der Thusen JH, Twickler MT, Aten J. The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis? J Endocrinol 208: 107-117, 2011.
63. Ruparel S, Henry MA, Akopian A, Patil M, Zeldin DC, Roman L, Hargreaves KM. Plasticity of cytochrome P450 isozyme expression in rat trigeminal ganglia neurons during inflammation. Pain 153: 2031-2039, 2012.
64. Rushen J, Foxcroft G, De Passille AM. Nursing-induced changes in pain sensitivity, prolactin, and somatotropin in the pig. Physiol Behav 53: 265-270, 1993.
65. Scotland PE, Patil M, Belugin S, Henry MA, Goffin V, Hargreaves KM, Akopian AN. Endogenous prolactin generated during peripheral inflammation contributes to thermal hyperalgesia. Eur J Neurosci 34: 745-754, 2011.
66. Sessle BJ. Acute and chronic craniofacial pain: brainstem mechanisms of nociceptive transmission and neuroplasticity, and their clinical correlates. Crit Rev Oral Biol Med 11: 57-91, 2000.
67. Sessle BJ. Peripheral and central mechanisms of orofacial inflammatory pain. Int Rev Neurobiol 97: 179-206, 2011.
68. Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee SY, Kim SH, Lee MG, Choi YH, Kim J, Haber NA, Reichling DB, Khasar S, Levine JD, Oh U. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 99: 10150-10155, 2002.
69. Straub RH, Georgi J, Helmke K, Vaith P, Lang B. In polymyalgia rheumatica serum prolactin is positively correlated with the number of typical symptoms but not with typical inflammatory markers. Rheumatology (Oxford) 41: 423-429, 2002.
70. Straub RH, Zeuner M, Lock G, Scholmerich J, Lang B. High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis. Br J Rheumatol 36: 426-432, 1997.
71. Tamura I, Asada H, Maekawa R, Tanabe M, Lee L, Taketani T, Yamagata Y, Tamura H, Sugino N. Induction of IGFBP-1 expression by cAMP is associated with histone acetylation status of the promoter region in human endometrial stromal cells. Endocrinology 153: 5612-5621, 2012.
72. Trott JF, Hovey RC, Koduri S, Vonderhaar BK. Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein. J Mol Endocrinol 30: 31-47, 2003.
73. Tseng YH, Kessler MA, Schuler LA. Regulation of interleukin (IL)-1alpha, IL-1beta, and IL-6 expression by growth hormone and prolactin in bovine thymic stromal cells. Mol Cell Endocrinol 128: 117-127, 1997.
74. Verschuren JE, Enzlin P, Dijkstra PU, Geertzen JH, Dekker R. Chronic disease and sexuality: a generic conceptual framework. J Sex Res 47: 153-170, 2010.
75. Walker SE. Modulation of hormones in the treatment of lupus. Am J Manag Care 7: S486-S489, 2001.
76. Walker SE, Allen SH, McMurray RW. Prolactin and autoimmune disease. Trends Endocrinol Metab 4: 147-151, 1993.
77. Xie YL, Hassan SA, Qazi AM, Tsai-Morris CH, Dufau ML. Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor. Mol Cell Biol 29: 2546-2555, 2009.